The cannabis data analytics company will continue to trade on the Canadian Securities Exchange under the symbol “CBII.”
Based in Toronto, CB2 Insights is a medical cannabis-focused data firm. The company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector by providing predictive analytics tools, data-driven software and services. In addition, it operates 28 cannabis evaluation and education clinics in 12 US states.
CB2 Insights said in a statement Friday that no action is required by shareholders in connection with the ticker symbol change.
Shares of CB2 closed Thursday up 2% to C$0.26 on the Canadian Securities Exchange and were trading at US$0.20 on the OTCQB.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas